← FDA DRUG APPROVALS

FDA NDA · NDA021873

YAZ

Sponsor: BAYER HLTHCARE

APPLICATION
NDA021873
TYPE
NDA
ORIGINAL APPROVAL
2006-10-04
LATEST ACTION
2006-10-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

YAZPrescription
DROSPIRENONE 3MG, ETHINYL ESTRADIOL 0.02MG · TABLET · ORAL

Approval history

2006-10-04Type 6 - New Indication (no longer used) · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →